StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Monday. The firm issued a hold rating on the stock.
China Pharma Stock Performance
Shares of NYSE:CPHI opened at $0.26 on Monday. The company has a 50 day moving average of $0.29 and a two-hundred day moving average of $0.38. China Pharma has a 52-week low of $0.24 and a 52-week high of $1.95. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%. The firm had revenue of $1.37 million for the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- How to Calculate Inflation Rate
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 Tickers Leading a Meme Stock Revival
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Want to Profit on the Downtrend? Downtrends, Explained.
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
